2 results match your criteria: "Bioproducts and Advanced Materials Research Center (BioMA)[Affiliation]"
Controlled Release of Caffeic Acid and Pinocembrin by Use of nPSi-βCD Composites Improves Their Antiangiogenic Activity.
Pharmaceutics
February 2022
Center of Molecular Biology and Pharmacogenetics, Department of Basic Sciences, Scientific and Technological Bioresource Nucleus (BIOREN-UFRO), Universidad de La Frontera, Avenida Francisco Salazar 01145, Temuco 4811230, Chile.
Although polyphenols have great pharmacological potential, the main disadvantage is that they have low bioavailability at the desired site. Thus, the use of biocompatible systems for drug delivery is a strategy that is currently gaining great interest. The objective of this study is to evaluate the effect of microencapsulation of caffeic acid and pinocembrin on the antioxidant and antiangiogenic activity of both polyphenols, by the use of nPSi-βCD composite microparticles.
View Article and Find Full Text PDFUse of nPSi-βCD Composite Microparticles for the Controlled Release of Caffeic Acid and Pinocembrin, Two Main Polyphenolic Compounds Found in a Chilean Propolis.
Pharmaceutics
June 2019
Bioproducts and Advanced Materials Research Center (BioMA), Faculty of Engineering, Universidad Católica de Temuco, Avenida Rudecindo Ortega 02950, Temuco 4813302, Chile.
Propolis is widely recognized for its various therapeutic properties. These are attributed to its rich composition in polyphenols, which exhibit multiple biological properties (e.g.
View Article and Find Full Text PDF